References
1. Styne DM, Arslanian SA, Connor EL, et al. Pediatric
obesity-assessment, treatment, and prevention: An endocrine society
clinical practice guideline. J Clin Endocrinol Metab . 2017.
doi:10.1210/jc.2016-2573
2. Hruby A, Manson JAE, Qi L, et al. Determinants and consequences of
obesity. Am J Public Health . 2016. doi:10.2105/AJPH.2016.303326
3. Pi-Sunyer X. The medical risks of obesity. Postgrad Med . 2009.
doi:10.3810/pgm.2009.11.2074
4. Chan RSM, Woo J. Prevention of overweight and obesity: How effective
is the current public health approach. Int J Environ Res Public
Health . 2010. doi:10.3390/ijerph7030765
5. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity
and body mass index among adult survivors of childhood acute
lymphoblastic leukemia: A report from the childhood cancer survivor
study. J Clin Oncol . 2008. doi:10.1200/JCO.2008.16.3527
6. Reilly JJ. Obesity during and after treatment for childhood cancer.Endocr Dev . 2009. doi:10.1159/000207609
7. Skoczen S, Surmiak M, Strojny W. Survivors of acute lymphoblastic
leukemia and body mass changes. Expert Opin Drug Saf . 2010.
doi:10.1517/14740330903410213
8. Karaman S, Ercan O, Yildiz I, et al. Late effects of childhood ALL
treatment on body mass index and serum leptin levels. J Pediatr
Endocrinol Metab . 2010. doi:10.1515/JPEM.2010.23.7.669
9. Trimis G, Moschovi M, Papassotiriou I, Chrousos G,
Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in
young survivors of acute lymphoblastic leukemia in childhood as a target
for preventing disease. J Pediatr Hematol Oncol . 2007.
doi:10.1097/MPH.0b013e318059c249
10. van Waas M, Neggers SJCMM, Pieters R, van den Heuvel-Eibrink MM.
Components of the metabolic syndrome in 500 adult long-term survivors of
childhood cancer. Ann Oncol . 2009. doi:10.1093/annonc/mdp414
11. Geenen MM, Bakker PJM, Kremer LCM, Kastelein JJP, Leeuwen FEV.
Increased prevalence of risk factors for cardiovascular disease in
long-term survivors of acute lymphoblastic leukemia and Wilms tumor
treated with radiotherapy. Pediatr Blood Cancer . 2010.
doi:10.1002/pbc.22518
12. Zhang FF, Parsons SK. Obesity in Childhood Cancer Survivors: Call
for Early Weight Management. Adv Nutr . 2015.
doi:10.3945/an.115.008946
13. Copelan E. Hematopoietic Stem-Cell Transplantation. N Engl J
Med . 2006;354(17):1813-1826.
14. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell
transplantation (HCT)-specific comorbidity index: A new tool for risk
assessment before allogeneic HCT. Blood . 2005.
doi:10.1182/blood-2005-05-2004
15. Fleming DR, Rayens MK, Garrison J. Impact of obesity on allogeneic
stem cell transplant patients: A matched case-controlled study. In:American Journal of Medicine . ; 1997.
doi:10.1016/S0002-9343(96)00450-0
16. White M, Murphy AJ, Hallahan A, Ware RS, Fraser C, Davies PSW.
Survival in overweight and underweight children undergoing hematopoietic
stem cell transplantation. Eur J Clin Nutr . 2012.
doi:10.1038/ejcn.2012.109
17. Inaba H, Yang J, Kaste SC, et al. Longitudinal changes in body mass
and composition in survivors of childhood hematologic malignancies after
allogeneic hematopoietic stem-cell transplantation. J Clin Oncol .
2012. doi:10.1200/JCO.2011.40.0457
18. Ruble K, Hayat M, Stewart KJ, Chen A. Body composition after bone
marrow transplantation in childhood. Oncol Nurs Forum . 2012.
doi:10.1188/12.ONF.186-192
19. Child Growth Standards, WHO Anthro (version 3.1, June 2010) and
macros. In: World Health Organization, 2010. pp macro calculate the
indicators of the attained growth standards (length/height-for-age,
weight-for-age, weight-for-length, weight-for-height, b.
20. A SAS Program for CDC Growth Charts. In: Center for Disease Control,
2009. p The purpose of this SAS program is to easily generate a dataset
that contains indices of the anthropometric status of children from
birth to 20 years of age based on the 2000 CDC.
21. Obesity: preventing and managing the global epidemic. Report of a
WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii.
1–253.
22. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and
adult obesity in the United States, 2011-2012. JAMA - J Am Med
Assoc . 2014. doi:10.1001/jama.2014.732
23. Los Angeles County Department of Public Health. Obesity and
Related Mortality in Los Angeles County: A Cities and Communities Health
Report .; 2011.
24. Cohen A, Duell T, Socié G, et al. Nutritional status and growth
after bone marrow transplantation (BMT) during childhood: EBMT
late-effects working party retrospective data. Bone Marrow
Transplant . 1999. doi:10.1038/sj.bmt.1701769
25. Flowers MED, Martin PJ. How we treat chronic graft-versus-host
disease. Blood . 2015. doi:10.1182/blood-2014-08-551994
26. Jim HSL, Evans B, Jeong JM, et al. Sleep disruption in hematopoietic
cell transplantation recipients: Prevalence, severity, and clinical
management. Biol Blood Marrow Transplant . 2014.
doi:10.1016/j.bbmt.2014.04.010
27. McBride B, Fiese B, Dev DA, et al. Risk factors for
overweight/obesity in preschool children: An ecological approach.Child Obes . 2013. doi:10.1089/chi.2012.0150
28. Hjermstad MJ, Knobel H, Brinch L, et al. A prospective study of
health-related quality of life, fatigue, anxiety and depression 3-5
years after stem cell transplantation. Bone Marrow Transplant .
2004. doi:10.1038/sj.bmt.1704561
29. Skaarud KJ, Veierød MB, Lergenmuller S, Bye A, Iversen PO,
Tjønnfjord GE. Body weight, body composition and survival after 1 year:
follow-up of a nutritional intervention trial in allo-HSCT recipients.Bone Marrow Transplant . 2019. doi:10.1038/s41409-019-0638-6
30. Monteiro R, Azevedo I. Chronic inflammation in obesity and the
metabolic syndrome. Mediators Inflamm . 2010.
doi:10.1155/2010/289645
31. Bubalo J, Carpenter PA, Majhail N, et al. Conditioning Chemotherapy
Dose Adjustment in Obese Patients: A Review and Position Statement by
the American Society for Blood and Marrow Transplantation Practice
Guideline Committee. Biol Blood Marrow Transplant . 2014.
doi:10.1016/j.bbmt.2014.01.019
32. Gleimer M, Li Y, Chang L, et al. Baseline body mass index among
children and adults undergoing allogeneic hematopoietic cell
transplantation: Clinical characteristics and outcomes. Bone
Marrow Transplant . 2015. doi:10.1038/bmt.2014.280
33. Nakao M, Chihara D, Niimi A, et al. Impact of being overweight on
outcomes of hematopoietic SCT: A meta-analysis. Bone Marrow
Transplant . 2014. doi:10.1038/bmt.2013.128
34. Barker CC, Agovi MA, Logan B, et al. Childhood Obesity and Outcomes
after Bone Marrow Transplantation for Patients with Severe Aplastic
Anemia. Biol Blood Marrow Transplant . 2011.
doi:10.1016/j.bbmt.2010.08.019
35. Couto-Silva AC, Trivin C, Esperou H, Michon J, Fischer A, Brauner R.
Changes in height, weight and plasma leptin after bone marrow
transplantation. Bone Marrow Transplant . 2000.
doi:10.1038/sj.bmt.1702718
36. Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I.
Endocrine dysfunction and parameters of the metabolic syndrome after
bone marrow transplantation during childhood and adolescence. Bone
Marrow Transplant . 2006. doi:10.1038/sj.bmt.1705374
37. Couto-Silva AC, Trivin C, Esperou H, et al. Final height and gonad
function after total body irradiation during childhood. Bone
Marrow Transplant . 2006. doi:10.1038/sj.bmt.1705455
38. Poirier P, Martin J, Marceau P, Biron S, Marceau S. Impact of
bariatric surgery on cardiac structure, function and clinical
manifestations in morbid obesity. Expert Rev Cardiovasc Ther .
2004. doi:10.1586/14779072.2.2.193
39. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular
disease: Pathophysiology, evaluation, and effect of weight loss.Arterioscler Thromb Vasc Biol . 2006.
doi:10.1161/01.ATV.0000216787.85457.f3
40. Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin
cardiomyopathy. Cardiology . 2010. doi:10.1159/000265166
41. Warburg O. On the origin of cancer cells. Science (80- ) .
1956. doi:10.1126/science.123.3191.309
42. Tan-Shalaby J. Ketogenic Diets and Cancer: Emerging Evidence.Fed Pract . 2017.
43. Di Biase S, Longo VD. Fasting-induced differential stress
sensitization in cancer treatment. Mol Cell Oncol . 2016;3(3):1-2.
doi:10.1080/23723556.2015.1117701
44. Longo VD, Fontana L. Calorie restriction and cancer prevention:
metabolic and molecular mechanisms. Trends Pharmacol Sci . 2010.
doi:10.1016/j.tips.2009.11.004
45. Adlercreutz H. Western diet and western diseases: Some hormonal and
biochemical mechanisms and associations. Scand J Clin Lab Invest .
1990. doi:10.1080/00365519009085798
46. Kuriki K, Tajima K. The increasing incidence of colorectal cancer
and the preventive strategy in Japan. Asian Pacific J Cancer
Prev . 2006.
47. Craig WJ. Health effects of vegan diets. In: American Journal
of Clinical Nutrition . ; 2009. doi:10.3945/ajcn.2009.26736N
48. Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and
risk of cancer: An updated systematic review and meta-analysis of
observational studies. Cancer Med . 2015;4(12):1933-1947.
doi:10.1002/cam4.539
49. Gray A, Dang BN, Moore TB, Clemens RA, Pressman P. A Review of
Nutrition and Dietary Interventions in Oncology. SAGE Open Med .